Armistice Capital, LLC Reports 6.75% Stake in Bicycle Therapeutics plc (BCYC)

Armistice Capital, LLC, along with its managing member Steven Boyd, has filed a Schedule 13G/A reporting a significant stake in Bicycle Therapeutics plc (BCYC). As of the event date on March 31, 2026, the reporting persons beneficially own 3,398,000 American Depositary Shares, which represents approximately 6.75% of the company's outstanding shares. This filing marks an increase from a previously reported 0% ownership position, indicating a new substantial holding by the investment manager. The shares are held directly by the Armistice Capital Master Fund Ltd., for which Armistice Capital, LLC serves as the investment manager. Under their investment management agreement, Armistice Capital exercises shared voting and dispositive power over these securities. The filing is an amendment to a previous statement and was submitted on May 15, 2026. The reporting persons have certified that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.